We are live on ! Find out more
Fiera Capital (Canada)

Fiera Capital (Canada) Portfolio holdings

AUM $27.6B
1-Year Est. Return 23.56%
This Fund
S&P 500
This Quarter Est. Return
-5.12%
1 Year Est. Return
+23.56%
3 Year Est. Return
+73.59%
5 Year Est. Return
+96.75%
10 Year Est. Return
+462.14%
AUM
$27.9B
AUM Growth
-$5.85B
Cap. Flow
-$39.5B
Cap. Flow %
-141.74%
Top 10 Hldgs %
40.08%
Holding
599
New
23
Increased
121
Reduced
323
Closed
59

Sector Composition

Rank Sector Weight
1 Financials 22.2%
2 Technology 17.7%
3 Healthcare 15.57%
4 Industrials 13.72%
5 Consumer Discretionary 11.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXA icon
326
Fox Class A
FOXA
$26.9B
$1.58M 0.01%
+51,500
New +$1.74M
WIA
327
Western Asset Inflation-Linked Income Fund
WIA
$186M
$1.57M 0.01%
175,284
-413
-0.2% -$4.14K
ALYA
328
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$1.56M 0.01%
801,615
REGN icon
329
Regeneron Pharmaceuticals
REGN
$80.8B
$1.54M 0.01%
2,238
-2,008
-47% -$1.26M
MELI icon
330
Mercado Libre
MELI
$92.3B
$1.53M 0.01%
1,851
-1,321
-42% -$1.14M
TDY icon
331
Teledyne Technologies
TDY
$32B
$1.53M 0.01%
4,537
-1,094
-19% -$418K
CAH icon
332
Cardinal Health
CAH
$55.4B
$1.51M 0.01%
22,715
VAL icon
333
Valaris
VAL
$5.47B
$1.51M 0.01%
+30,904
New +$1.48M
BTZ icon
334
BlackRock Credit Allocation Income Trust
BTZ
$956M
$1.5M 0.01%
157,520
-367
-0.2% -$4.03K
BKNG icon
335
Booking.com
BKNG
$161B
$1.46M 0.01%
24,325
+1,100
+5% +$82.7K
RPRX icon
336
Royalty Pharma
RPRX
$25.3B
$1.46M 0.01%
36,375
-8,275
-19% -$353K
GEN icon
337
Gen Digital
GEN
$17.5B
$1.44M 0.01%
71,370
+325
+0.5% +$7.51K
PVH icon
338
PVH
PVH
$4.04B
$1.42M 0.01%
31,695
BLW icon
339
BlackRock Limited Duration Income Trust
BLW
$493M
$1.42M 0.01%
116,947
-276
-0.2% -$3.64K
WEA
340
Western Asset Premier Bond Fund
WEA
$124M
$1.41M 0.01%
144,023
-334
-0.2% -$3.62K
ABT icon
341
Abbott
ABT
$187B
$1.39M 0.01%
14,407
+4,224
+41% +$450K
CDW icon
342
CDW
CDW
$17B
$1.36M ﹤0.01%
8,739
+119
+1% +$20.4K
FPF
343
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$1.34M ﹤0.01%
80,688
-198
-0.2% -$3.75K
GNRC icon
344
Generac Holdings
GNRC
$12.5B
$1.34M ﹤0.01%
7,499
TMO icon
345
Thermo Fisher Scientific
TMO
$220B
$1.28M ﹤0.01%
2,741
-92
-3% -$51.5K
SNY icon
346
Sanofi
SNY
$104B
$1.27M ﹤0.01%
36,324
+2,008
+6% +$89.5K
EPAM icon
347
EPAM Systems
EPAM
$5.03B
$1.27M ﹤0.01%
3,513
+982
+39% +$376K
WBD icon
348
Warner Bros
WBD
$67.1B
$1.25M ﹤0.01%
108,600
-20,000
-16% -$272K
DVAX
349
DELISTED
Dynavax Technologies
DVAX
$1.24M ﹤0.01%
179,463
-5,327
-3% -$69.4K
PFGC icon
350
Performance Food Group
PFGC
$18B
$1.23M ﹤0.01%
28,571

Similar funds

Fiera Capital (Canada)'s Q3 2022 Portfolio in Review

As of Q3 2022, Fiera Capital (Canada) held 599 positions worth $27.9B, down 17% from $33.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fiera Capital (Canada) withdrew a net $39.5B in Q3 2022, closing 59 positions and reducing 323 holdings. Its most notable exit was Zentalis Pharmaceuticals, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Fiera Capital (Canada) opened a new position in Tyler Technologies worth $45.5M.

  • Fiera Capital (Canada)'s largest Q3 2022 buy was Tyler Technologies: 139,291 shares worth $45.5M.
  • Fiera Capital (Canada) added most to Lattice Semiconductor in Q3 2022, an estimated $36.4M increase.
  • Fiera Capital (Canada)'s biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $37.7B.
  • Fiera Capital (Canada) fully exited Zentalis Pharmaceuticals in Q3 2022, selling an estimated $10.2M.
  • Fiera Capital (Canada)'s ten largest holdings make up 40% of its $27.9B portfolio in Q3 2022.
  • Fiera Capital (Canada) opened 23 new positions and closed 59 in Q3 2022.
  • Fiera Capital (Canada)'s portfolio value fell 17% quarter-over-quarter to $27.9B.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2022, filed 3 Nov 2022.